600,000 Euro Seed Funding Dutch Biotech Coating Startup
Nanotechnology Seed Investment
Fabian Stein
July 13, 2017
Introduction
LipoCoat BV, a spin-off from the MESA+ institute at University of Twente, gathered €600,000 in seed funding. 600,000 Euro Seed FundingLipoCoat BV secured €600,000 with grants, a Redmedtech Ventures loan, and investments from LLX2.
600,000 Euro Seed FundingLipoCoat BV secured €600,000 with grants, a Redmedtech Ventures loan, and investments from LLX2. The funds accelerate early product development for biocompatible medical coatings.
Fabian Stein
Business Development & Global Sales
Fabian Stein leads Business Development and Global Sales for the Lipocoat Company, connecting the coating platforms to medical device manufacturers.
Updates
Also interesting
LipoCoat and SonoCoat have earned recognition from leading institutions and regulatory bodies. Our coatings meet the highest standards for biocompatibility and clinical efficacy.
Publication
SonoCoat® Technology Featured in Scientific Publications
Four independent peer-reviewed studies have evaluated SonoCoat®, from EUS-FNA needles to prostate brachytherapy. What each one tested, and what it found.
Document
When the Needle Disappears: SonoCoat® in Three Clinical Applications
Real-time ultrasound guidance is now standard for CVC placement, yet needles still vanish at steep insertion angles. What SonoCoat® changes in vascular access, biopsy and regional anesthesia.
News
TFDA Approves CEMMA and LipoCoat Coated Antifouling CVC Catheter
Taiwan FDA approves CEMMA and LipoCoat co-developed coated antifouling central venous catheter for critical care.